We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 11.35%
4 Consumer Discretionary 9.79%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTOR
1376
DELISTED
MERITOR, Inc.
MTOR
– –
-81,300
Closed -$1.57M
WBT
1377
DELISTED
Welbilt, Inc.
WBT
– –
-256,059
Closed -$5.35M
COHR
1378
DELISTED
Coherent Inc
COHR
– –
-2,900
Closed -$499K
HSTO
1379
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-2,218
Closed -$2.57M
MGLN
1380
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-50,877
Closed -$3.67M
CLDR
1381
DELISTED
Cloudera, Inc.
CLDR
– –
-446,387
Closed -$7.88M
MXIM
1382
DELISTED
Maxim Integrated Products
MXIM
– –
-8,075
Closed -$455K
CMD
1383
DELISTED
Cantel Medical Corporation
CMD
– –
-51,709
Closed -$4.76M
GLUU
1384
DELISTED
Glu Mobile Inc.
GLUU
– –
-17,600
Closed -$131K
VRTU
1385
DELISTED
Virtusa Corporation
VRTU
– –
-9,200
Closed -$494K
MYOK
1386
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-4,700
Closed -$306K
DLPH
1387
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
– –
-11,782
Closed -$370K
LOGM
1388
DELISTED
LogMein, Inc.
LOGM
– –
-2,600
Closed -$232K
AXE
1389
DELISTED
Anixter International Inc
AXE
– –
-12,100
Closed -$851K
MDR
1390
DELISTED
McDermott International
MDR
– –
-14,633
Closed -$270K
SRCI
1391
DELISTED
SRC Energy Inc
SRCI
– –
-289,600
Closed -$2.58M
AABA
1392
DELISTED
Altaba Inc
AABA
– –
-6,500
Closed -$443K
HIFR
1393
DELISTED
InfraREIT, Inc.
HIFR
– –
-221,213
Closed -$4.68M
ESL
1394
DELISTED
Esterline Technologies
ESL
– –
-5,300
Closed -$482K
ITG
1395
DELISTED
Investment Technology Group Inc
ITG
– –
-31,100
Closed -$674K
ESIO
1396
DELISTED
Electro Scientific Industries
ESIO
– –
-107,800
Closed -$1.88M
TSRO
1397
DELISTED
TESARO, Inc.
TSRO
– –
-146,419
Closed -$5.71M
CYHHZ
1398
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$0 ﹤0.01%
304,623
– –
XOXO
1399
DELISTED
Xo Group Inc
XOXO
– –
-24,882
Closed -$858K
ESRX
1400
DELISTED
Express Scripts Holding Company
ESRX
– –
-128,627
Closed -$12.2M
53 54 55
56
57

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.